Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Revolution Medicines

Request full access

Targeted therapies for previously undruggable RAS-addicted cancers

Redwood City, United StatesFounded 2015Biotech & Life Sciences
Valuation $38B Market cap · Aug/2026
Revenue $103M Latest reported FY

At a glance

Status
Listed
Founded
2015
Headquarters
Redwood City, United States
Listing
IPO 2020
Sector
Biotech & Life Sciences
Power Law
Decacorn$10B+ valuation tier

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom
News
News Tango's vopimetostat combination shows 82% response rate in pancreatic cancer at ESMO 2026 Oct 24, 2026 News EMA committee backs Revolution Medicines' Rasonque for metastatic pancreatic cancer Oct 16, 2026 News Revolution Medicines wins FDA approval for Rasonque, the first drug to target the genetic driver of pancreatic cancer Aug 26, 2026

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later8 investors entered at this stage

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Redwood City HQ
Book a demo for the full country breakdown
Web traffic by country
160K monthly visits
across markets
🇺🇸 United States49.6%
🇬🇧 United Kingdom6.5%
🇮🇳 India5.6%
🇨🇦 Canada5.1%
🇨🇭 Switzerland2.9%
Top 5 markets shown

Patents

Estimated portfolio value
$68M

86 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Revolution Medicines was the backer or acquirer, 2018–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

2 deals across Revolution Medicines's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Revolution Medicines's portfolio, mapped.

        Stage
        Period
        2 of 2 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Revolution Medicines on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Revolution Medicines on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles